IT stock under ₹50 hits upper circuit ahead of Q1 results 2025. Do you own?
The Board of Directors of the Company will be held on Thursday, the 14th day of August, 2025, to consider and approve the standalone and consolidated audited financial results of Blue Cloud Softech Solutions for the 01st quarter ended on 30.06.2025.
The board meeting of Blue Cloud Softech Solutions may consider any other business with the permission of the chair.
Blue Cloud Softech Solutions in the previous month had announced the launch of the BlueHealth Platform. Blue Cloud Softech Solutions has announced the BluHealth Platform, a healthcare platform powered by artificial intelligence.
The platform is a step toward improving their visibility in the global digital health sector.
Blue Cloud Softech Solutions Limited announced the launch of its BlueHealth Platform v2.0 healthcare platform, which transitioned from a proof-of-concept to an AI-integrated, enterprise-grade solution for large-scale healthcare delivery.
Blue Cloud Softech Solutions opened at ₹ 27.63 on the BSE on Monday. At the time of opening, the IT stock under ₹ 50, Blue Cloud Softech Solutions, share price was 5% higher compared to the previous session's closing price of ₹ 26.32. Since the ₹ 27.63 level for IT stock under ₹ 50, the Blue Cloud Softech Solutions share price was also upper price band of the stock and hence the Blue Cloud Softech Solutions share price continued to save at these levels with gains of close to 5%
The IT stock under ₹ 50: Blue Cloud Softech Solutions share price having risen 385% in the last 5 years has given multibagger returns to the investors.
Disclaimer: The views and recommendations above are those of individual analysts or brokerage companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
ITC Hotels hopes to go beyond own target, have 220 hotels by '30
1 2 Kolkata: ITC Hotels chairman Sanjiv Puri said on Monday that the company aimed to have a portfolio of 220 operational hotels with over 20,000 keys by 2030. He was speaking to shareholders at the first AGM after the demerger of ITC Hotels. The company had earlier set a target of 200 properties by 2030. "The company is looking at all opportunities, either through its investments or through management contracts. As far as the roadmap is concerned, what we said when the listing happened was that by 2030, we will have 200 hotels. As we stand today, we believe that this will be easily surpassed and will be 220," he said. Currently, the company has 140 hotels. The hotel business of the diversified conglomerate ITC Ltd was demerged into ITC Hotels Ltd with effect from Jan 1, 2025. The equity shares of the company were listed on the NSE and BSE on Jan 29. You Can Also Check: Kolkata AQI | Weather in Kolkata | Bank Holidays in Kolkata | Public Holidays in Kolkata During his speech at the AGM, the first time following the hospitality major's listing on the stock exchanges, Puri said, "We stand today at a transformative juncture as significant opportunities unfold for the tourism and hospitality sector. ITC Hotels is well poised to script a new chapter with sharp strategic focus, enhanced agility, soulful hospitality, and a commitment to long-term value creation." He said the travel, tourism, and hospitality sector in India is riding a wave of resurgence, with a record Rs 3.1 trillion international visitor spending in 2024. Domestic travel spending reached Rs 15.5 trillion, which is 22% above 2019 levels. "Your company signed 30 management and franchise contracts last year, contributing to a healthy pipeline of 58 hotels with over 5,300 keys and is well on the way to crossing our target of 200 hotels by 2030," Puri said. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.
Mint
6 hours ago
- Mint
₹1.12 to ₹38.72: Multibagger penny stock turns ₹1 lakh into ₹34.57 lakh in five years
Spice Lounge Food Works (formerly known as Shalimar Agencies), one of the country's fast-growing food and tech companies, has delivered handsome returns to Dalal Street investors, with its shares continuing to climb, breaking record highs, and emerging as one of the biggest wealth creators in the Indian stock market in recent times. The stock has been hitting upper circuit limits in recent months, causing the wealth of its shareholders to rise sharply, as the company is entirely owned by retail shareholders with zero per cent promoter stake, according to the latest data available on the BSE. Founded in 2019 in India, the company operates in India, the USA, and Canada. It holds exclusive franchise rights for global brands like Buffalo Wild Wings, Wingzone, eTouch, and TekSoft, and it owns four original brands—Blaze Kebabs, Xora, Salud, and Sunburn Union. Focused on innovation and quality, the company is rapidly expanding its global footprint, according to its website. It also provides computer and outsourcing services in the information technology sector, including data, voice, or video collection and processing, as well as call center services. Last week, the company informed the exchanges about its name change to Spice Lounge Food Works Limited from Shalimar Agencies, effective from today. From a trading price of ₹ 4.60 apiece one year ago, the stock has surged 741% to its current level of ₹ 38.72 apiece. Even during periods of sharp volatility in the small-cap segment, the stock did not lose momentum and continued to surge higher, resulting in a 1,043% jump over the last three years and 3,143% over the last five years, raising from ₹ 1.12 apiece. The stellar rise in the stock price has also pushed the company's market capitalization to ₹ 2,645 crore as of August 11. The company is expected to announce its June quarter numbers on August 14 (Thursday). It ended FY25 with a net profit of ₹ 6 crore on revenue of ₹ 105 crore. The massive rise in the share price over a short period has significantly boosted investor wealth. An investor who had put ₹ 1 lakh into the stock five years ago and held onto it would have seen its value grow to ₹ 34.57 lakh, highlighting the wealth-creating potential of the stock market when the right counters are chosen. Meanwhile, the stock has been trading on an ex-split basis in the ratio of 1:10 since March 2025. The above calculation does not factor in the post-split benefit.
The Hindu
6 hours ago
- The Hindu
Zydus gets U.S. FDA nod for Diltiazem Hydrochloride tablets
Generic drugmaker Zydus Lifesciences has received final approval from the U.S. Food and Drug Administration (U.S. FDA) for Diltiazem Hydrochloride tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg. A generic of Cardizem Tablets, the drug is indicated for management of chronic stable angina and angina due to coronary artery spasm. Diltiazem Hydrochloride tablets had annual sales of $13.9 million in the U.S., Zydus said, citing IQVIA MAT June 2025 numbers. The approved drug will be produced at its plant in Baddi, Himachal Pradesh, the company said. Belonging to a class of drugs called calcium-channel blockers, Diltiazem works by relaxing blood vessels, which reduces the workload on the heart and increases blood and oxygen supply to the heart muscle, it said. Zydus Lifesciences shares closed 2.18% higher at ₹955.90 apiece on the BSE.
